ReGen Therapeutics share price RGT - UK share prices, stock market news and charts.

RGT news

RGT trades share chat for ReGen Therapeutics

Chat

ADD to watchlist

Uk Share Prices

ReGen Therapeutics Share price

Symbol: RGT Share price: 0.63 % Change: -28.57 % Change: -0.25

Bid:	0.50
Offer:	0.75
Volume:	22,380,939.0
Prev close:	0.88
Shares issued:	389.446548
52 week high:	3.88
Index:

Last Change:	02-18 16:18
Open:	0.88
High:	0.85
Low:	0.45
Security type:	Equity
52 week low:	0.45
Market Cap:	0.89

RGT historical prices

RGT quick charts

RGT analysis chart company results calendar

Calendar

Sector: Pharmaceuticals & Biotechnology

Latest ReGen Therapeutics share trades
Date	Time	Buy/Sell	Amount	Price	Value
18/02/11	04:38pm	Sell	250000	0.50	1250.00
18/02/11	04:09pm	Sell	500000	0.50	2500.00
See more ReGen Therapeutics share trades »

Latest ReGen Therapeutics share news
Small caps round-up: AEC Education, Treveria, ReGen... Small caps round-up: ANT, Ariana Resources, Patagonia Gold... Small caps round-up: Nautical Petroleum, ThirdForce, Allied Gold...
See more ReGen Therapeutics share news »

ReGen Therapeutics Share chat - Message board.
There's been no chat about this share, be first to post some! - Click here.

Data is provided by Digital Look Corporate Solutions incorporating their share prices, data, news and fundamentals on this site. Please read the terms and conditions of useage of this data. This data is provided for information purposes only and will be delayed by at least 15 minutes at most times.

Enter share symbol

Search share prices A to Z

Latest ReGen Therapeutics headlines
Where Is Biotechnology's Next 'Anti-PD-1'? - Seeking Alpha Tue, 18 Jun 2013 12:01In this space, success is measured in months, and every few years it seems as though a new therapeutic approach is developed; that approach is warmly welcomed by Wall Street. In 2009/2010, it was ... However, problems in manufacturing for Dendreon led ... Osiris - Can Stem Cells Lead To Profits? - Seeking Alpha Mon, 17 Jun 2013 20:07Lastly, the company has Osteocell XC in early trials, which targets focal bone regeneration. Strategy. Osiris saw an impressive climb from about $6.50 a share in early March of this year to About $11.50. The 52-week high is at ... Analyst firm Piper ... SmithOnStocks Opines Week Of June 2, 2013 - Seeking Alpha Mon, 03 Jun 2013 11:00I spent a day at the Marcum MicroCap Conference in New York and this led to updates on ImmunoCellular Therapeutics (IMUC) and Northwest Biotherapeutics (NWBO), two companies I have been actively involved with. I have also provided brief comments on ...

Uk Share Prices

ReGen Therapeutics Share price

Top Shares pages

More share features

POPULAR Share Prices